Open Label Study to Evaluate the Safety and Efficacy of Lenalidomide With MOR00208 in Patients With R-R DLBCL
Public ClinicalTrials.gov record NCT02399085. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Single-Arm, Open-Label, Multicentre Study to Evaluate the Safety and Efficacy of Lenalidomide Combined With MOR00208 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R-R DLBCL)
Study identification
- NCT ID
- NCT02399085
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- MorphoSys AG
- Industry
- Enrollment
- 81 participants
Conditions and interventions
Conditions
Interventions
- Tafasitamab Drug
- Lenalidomide Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 28, 2016
- Primary completion
- Nov 13, 2022
- Completion
- Apr 18, 2023
- Last update posted
- Oct 22, 2023
2016 – 2023
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center | Bakersfield | California | 93309 | — |
| UCLA - David Geffen School of Medicine | Los Angeles | California | 90095 | — |
| Cancer Care - Torrance Memorial Physician Network | Redondo Beach | California | 90277 | — |
| Central Coast Medical Oncology Corporation | Santa Maria | California | 93454 | — |
| St. Mary's Hospital And Regional Medical Center | Grand Junction | Colorado | 81501 | — |
| Norwalk Hospital | Norwalk | Connecticut | 06856 | — |
| St. Joseph Mercy Hospital Cancer Care Center | Ypsilanti | Michigan | 48179 | — |
| Ohio State University Medical Center | Columbus | Ohio | 43210 | — |
| Charleston Hematology Oncology Associates | Charleston | South Carolina | 29414 | — |
| Tyler Hematology-Oncology | Tyler | Texas | 75701 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 47 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02399085, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 22, 2023 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02399085 live on ClinicalTrials.gov.